Show simple item record

The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer

dc.contributor.authorKoca, D.
dc.contributor.authorUlas, A.
dc.contributor.authorBerk, V.
dc.contributor.authorKucukoner, M.
dc.contributor.authorBalakan, O.
dc.contributor.authorOzturk, M. A.
dc.contributor.authorBenekli, M.
dc.contributor.authorGumus, M.
dc.contributor.authorYilmaz, U.
dc.contributor.authorOzkan, S.
dc.contributor.authorBuyukberber, S.
dc.contributor.authorTuran, N.
dc.contributor.authorDane, F.
dc.contributor.authorOzdemir, N.
dc.contributor.authorUstaalioglu, B. B. Oven
dc.contributor.authorOztop, I.
dc.date.accessioned2021-03-04T12:41:46Z
dc.date.available2021-03-04T12:41:46Z
dc.date.issued2011
dc.identifier.citationTuran N., Koca D., Dane F., Ozdemir N., Ustaalioglu B. B. O. , Oztop I., Ulas A., Berk V., Kucukoner M., Balakan O., et al., "The impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer", JOURNAL OF CLINICAL ONCOLOGY, cilt.29, sa.15, 2011
dc.identifier.issn0732-183X
dc.identifier.otherav_789c98cc-acb3-482b-8dfc-36f6d7a0a645
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/82724
dc.identifier.urihttps://doi.org/10.1200/jco.2011.29.15_suppl.e14120
dc.language.isoeng
dc.subjectOnkoloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.titleThe impact of bevacizumab usage on patients who were curative resected for liver-confined metastases from colorectal cancer
dc.typeMakale
dc.relation.journalJOURNAL OF CLINICAL ONCOLOGY
dc.contributor.department, ,
dc.identifier.volume29
dc.identifier.issue15
dc.contributor.firstauthorID200466


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record